Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jan
5
2022
Philadelphia Enacts Ordinance to Prohibit Pre-Employment Marijuana Testing Proskauer Rose LLP
Jan
4
2022
Legal Challenge to BE Food Disclosure Standard Keller and Heckman LLP
Jan
4
2022
Cannabis Legislation Year-in-Review Sheppard, Mullin, Richter & Hampton LLP
Jan
4
2022
Unpacking Averages: Likelihood of FDA Medical Device Inspections Epstein Becker & Green, P.C.
Jan
3
2022
Medical Marijuana Front and Center as Mississippi Lawmakers Reconvene for 2022 Legislative Session Bradley Arant Boult Cummings LLP
Jan
3
2022
Healthcare Res. Mgmt. Grp., LLC v. Econatura All Healthy World, LLC – A Cautionary Tale: Meticulous or Careless Strategy Required to Prove Your Trade Secret Claim Sheppard, Mullin, Richter & Hampton LLP
Jan
3
2022
The Virtues of Claiming Precisely What the FDA Approved! Finnegan
Jan
3
2022
FDA Proposes Stricter Limits on Histamine in Fish Keller and Heckman LLP
Dec
30
2021
San Francisco Passes Measure Requiring Sick Leave for Domestic Workers – “First of Its Kind” Sheppard, Mullin, Richter & Hampton LLP
Dec
30
2021
CMS Plans Enforcement, Sets New Deadlines for COVID Vaccination Mandate Davis|Kuelthau, s.c.
Dec
29
2021
CDC Shortens Recommended COVID-19 Quarantine and Isolation Periods Varnum LLP
Dec
28
2021
CDC’s Latest Guidance Shortens Quarantine Duration for Some COVID-19 Positive Individuals Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Dec
28
2021
Recent New York Federal Court Decisions Hold that the ADA Does Not Cover Websites ArentFox Schiff LLP
Dec
28
2021
Two New State Laws Could Disrupt the Vapor Industry Keller and Heckman LLP
Dec
28
2021
FDA Issues Latest Draft Guidance on the Use of Real-World Data and Evidence to Support Regulatory Decision-Making for Drug and Biological Products Foley & Lardner LLP
Dec
27
2021
CMS Plans to Regulate Pharmacy Benefit Manager DIR Fees Dinsmore & Shohl LLP
Dec
23
2021
Vaping Will Not Make You Well Foley & Lardner LLP
Dec
23
2021
FDA Updates Guidance on Exemptions from FSMA Keller and Heckman LLP
Dec
22
2021
Chicago Issues COVID-19 Vaccine Requirements for Restaurants, Bars, Gyms, Entertainment Venues Jackson Lewis P.C.
Dec
22
2021
FDA Update on China Food Facility Registration Keller and Heckman LLP
Dec
21
2021
New Prescription Drug and Health Care Spending Reporting Requirements from a Carrier and Plan Service Provider Perspective Foley & Lardner LLP
Dec
21
2021
Group Health Plans Subject to New Prescription Drug and Health Care Spending Reporting Requirements Foley & Lardner LLP
Dec
21
2021
Class-Action Against Whole Foods Dismissed Keller and Heckman LLP
Dec
21
2021
White May Not Be the Trend in 2022: EU Bans Whitening Food additive E171 as of January 1, 2022 Sheppard, Mullin, Richter & Hampton LLP
Dec
21
2021
More Whiplash — DC Brings Back Mask Mandate and Encourages Vaccine Mandates Proskauer Rose LLP
Dec
21
2021
District Court Rejects Purdue Pharma’s Chapter 11 Plan Over Non-Consensual Releases Provided to Sackler Family Squire Patton Boggs (US) LLP
Dec
17
2021
EC Denies Authorization of Titanium Dioxide (E171) as a Feed Additive for All Animal Species, Requires Products Be Withdrawn from the Market in 2022 Bergeson & Campbell, P.C.
Dec
17
2021
President Biden Signs Executive Order to Address Drug Trafficking Cadwalader, Wickersham & Taft LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins